Personal Info

Sign Up:

First Name *

* Required

Last Name *

* Required

Email *

* Required

Job Title *

* Required

Company *

* Required

Country *

* Required

Elsevier Inc. may contact you to share the latest updates about products, services, promotions, and events. If you do not wish to receive such messages, please check this box. * Required

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

The Creme RIFM Aggregate Exposure Model and Its Strategic Roles in QRA2 and the RIFM Safety Assessment Program

Available On Demand

Learn more about the Creme RIFM Aggregate Exposure Model and an in-depth review of the Quantitative Risk Assessment (QRA2). Learn how QRA2 changed from QRA1 and how we use the Creme RIFM Model in the QRA2. We will also focus on how the Creme RIFM Aggregate Exposure Model is used to derive Maximum Acceptable Concentrations based on all toxicological endpoints in the RIFM Safety Assessments.

Speakers:

Professor Aristidis Tsatsakis

Director of the Department of Forensic Sciences & Toxicology
Medical School, University of Crete
View Biography

Dr. Anne Marie Api

Vice President
Research Institute for Fragrance Materials
View Biography

John O’Brien, PhD

Head of Data Modelling and Statistics
Creme Global
View Biography